Medication intake may result in reduced ghrelin levels within the body [130, 133], leading to an imbalance between ghrelin and leptin [134], as well as changes in the ratio of acylated and unacylated growth hormone-releasing peptides [135], resulting in obesity. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.